Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
NCT ID: NCT00323570
Last Updated: 2012-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE3
INTERVENTIONAL
2006-05-31
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients
NCT01563523
Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury
NCT00123591
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding
NCT00184548
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
NCT00127283
Dose Response to Recombinant Factor VIIa When Administered for Bleed
NCT00104455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
activated recombinant human factor VII
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Novo Nordisk A/S
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bartholomew Tortella, MD
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novo Nordisk Clinical Trial Call Center
Phoenix, Arizona, United States
Novo Nordisk Clinical Trial Call Center
Los Angeles, California, United States
Novo Nordisk Clinical Trial Call Center
Sacramento, California, United States
Novo Nordisk Clinical Trial Call Center
Colorado Springs, Colorado, United States
Novo Nordisk Clinical Trial Call Center
Washington D.C., District of Columbia, United States
Novo Nordisk Clinical Trial Call Center
Gainesville, Florida, United States
Novo Nordisk Clinical Trial Call Center
Jacksonville, Florida, United States
Novo Nordisk Clinical Trial Call Center
Miami, Florida, United States
Novo Nordisk Clinical Trial Call Center
Chicago, Illinois, United States
Novo Nordisk Clinical Trial Call Center
Maywood, Illinois, United States
Novo Nordisk Clinical Trial Call Center
Indianapolis, Indiana, United States
Novo Nordisk Clinical Trial Call Center
Louisville, Kentucky, United States
Novo Nordisk Clinical Trial Call Center
Portland, Maine, United States
Novo Nordisk Clinical Trial Call Center
Baltimore, Maryland, United States
Novo Nordisk Clinical Trial Call Center
Boston, Massachusetts, United States
Novo Nordisk Clinical Trial Call Center
Detroit, Michigan, United States
Novo Nordisk Clinical Trial Call Center
Springfield, Missouri, United States
Novo Nordisk Clinical Trial Call Center
St Louis, Missouri, United States
Novo Nordisk Clinical Trial Call Center
Las Vegas, Nevada, United States
Novo Nordisk Clinical Trial Call Center
Camden, New Jersey, United States
Novo Nordisk Clinical Trial Call Center
Brooklyn, New York, United States
Novo Nordisk Clinical Trial Call Center
The Bronx, New York, United States
Novo Nordisk Clinical Trial Call Center
Greenville, North Carolina, United States
Novo Nordisk Clinical Trial Call Center
Winston-Salem, North Carolina, United States
Novo Nordisk Clinical Trial Call Center
Akron, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Cleveland, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Columbus, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Oklahoma City, Oklahoma, United States
Novo Nordisk Clinical Trial Call Center
Portland, Oregon, United States
Novo Nordisk Clinical Trial Call Center
Allentown, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Pittsburgh, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Providence, Rhode Island, United States
Novo Nordisk Clinical Trial Call Center
Memphis, Tennessee, United States
Novo Nordisk Clinical Trial Call Center
Nashville, Tennessee, United States
Novo Nordisk Clinical Trial Call Center
Fort Sam Houston, Texas, United States
Novo Nordisk Clinical Trial Call Center
Lackland Air Force Base, Texas, United States
Novo Nordisk Clinical Trial Call Center
San Antonio, Texas, United States
Novo Nordisk Clinical Trial Call Center
Salt Lake City, Utah, United States
Novo Nordisk Clinical Trial Call Center
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Trials at Novo Nordisk
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F7TRAUMA-1648
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.